| RS2145952877 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2145953393 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145953759 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145953853 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2145954110 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145954766 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145954876 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2145955095 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145955099 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS2145955176 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145955178 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145955299 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145956310 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145958521 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145959018 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145959393 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145959709 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145960213 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS2145960216 |
DNMT3B
|
Health Risk |
Pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS2145961078 |
TSPEAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis |
| RS2145961535 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2145963298 |
DMC1
|
Health Risk |
Pathogenic |
Azoospermia, Azoospermia |
| RS2145963581 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145964108 |
SMARCB1
|
Health Risk |
Pathogenic |
SMARCB1-related schwannomatosis, SMARCB1-related schwannomatosis |
| RS2145964352 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145965854 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145968180 |
CACNA1G
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia 42, early-onset |
| RS2145968996 |
CRYBB1
|
Health Risk |
Likely pathogenic |
— |
| RS2145970607 |
SMARCA4
|
Health Risk |
Likely pathogenic |
SMARCA4-related BAFopathy, Intellectual disability |
| RS2145970965 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS2145971047 |
SMARCA4
|
Health Risk |
Likely pathogenic |
SMARCA4-related BAFopathy, SMARCA4-related BAFopathy |
| RS2145971509 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145972429 |
ATP1A3
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS2145972442 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145972483 |
ATP1A3
|
Health Risk |
Pathogenic |
Alternating hemiplegia of childhood 2, Dystonia 12 |
| RS2145972497 |
ATP1A3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 99, Dystonia 12 |
| RS2145972624 |
ATP1A3
|
Health Risk |
Likely pathogenic |
— |
| RS2145974543 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2145977281 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS2145977394 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS2145977694 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS2145977758 |
ATP1A3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 99, Developmental and epileptic encephalopathy 99 |
| RS2145977887 |
ATP1A3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 99, Developmental and epileptic encephalopathy 99 |
| RS2145977981 |
SMARCB1
|
Health Risk |
Likely pathogenic |
— |
| RS2145977986 |
SMARCB1
|
Health Risk |
Likely pathogenic |
— |
| RS2145978723 |
SMARCB1
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 1, Hereditary cancer-predisposing syndrome |
| RS2145979078 |
CRYBA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 23, CRYBA4-related disorder |
| RS2145979349 |
ETHE1
|
Health Risk |
Likely pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS2145980559 |
SMARCB1
|
Health Risk |
Pathogenic |
Schwannomatosis, Schwannomatosis |
| RS2145980562 |
SMARCB1
|
Health Risk |
Pathogenic |
Schwannomatosis, Schwannomatosis |
| RS2145980854 |
CRYBA4
|
Health Risk |
Likely pathogenic |
Cataract 23, Cataract 23 |
| RS2145981153 |
SYNJ1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS2145982663 |
DNMT3B
|
Health Risk |
Pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS2145983235 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Undetermined early-onset epileptic encephalopathy, Undetermined early-onset epileptic encephalopathy |
| RS2145983859 |
GDF1
|
Health Risk |
Likely pathogenic |
— |
| RS2145984865 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS2145984908 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2145985085 |
CERS1
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2145988239 |
DYM
|
Health Risk |
Likely pathogenic |
— |
| RS2145989089 |
GDF1
|
Health Risk |
Pathogenic |
— |
| RS2145991515 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS2145991929 |
TCF3
|
Health Risk |
Pathogenic |
— |
| RS2145997089 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2146004773 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146004927 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2146005039 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146005256 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146005334 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146005460 |
CHEK2
|
Health Risk |
Likely pathogenic |
Breast carcinoma, Breast carcinoma |
| RS2146005603 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146005656 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146005743 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146005892 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146005916 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146006030 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146006354 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudopseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS2146007102 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146007633 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146009153 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146009225 |
FBXO7
|
Health Risk |
Likely pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2146010204 |
SMARCB1
|
Health Risk |
Pathogenic |
SMARCB1-related schwannomatosis, SMARCB1-related schwannomatosis |
| RS2146010499 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS2146014035 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2146014404 |
DNM2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease dominant intermediate B, Charcot-Marie-Tooth disease dominant intermediate B |
| RS2146015551 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146016503 |
TMPRSS6
|
Health Risk |
Likely pathogenic |
— |
| RS2146018043 |
KDM4B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2146018812 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS2146019063 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS2146019689 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS2146020978 |
LTBP4
|
Health Risk |
Likely pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS2146021137 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146021205 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146021332 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146021370 |
ETHE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS2146021402 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146021496 |
LTBP4
|
Health Risk |
Pathogenic |
— |
| RS2146022423 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146022577 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146022784 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |